Quinoline scaffolds drive new wave of antiprotozoal drug discovery
The burden of protozoan disease is not evenly distributed across the globe, and this asymmetry shapes nearly every aspect of ...
The burden of protozoan disease is not evenly distributed across the globe, and this asymmetry shapes nearly every aspect of ...
Trypanosoma cruzi, the single-celled parasite behind Chagas disease, has long frustrated drug developers... One of the more striking aspects of ...
Deep inside the metabolic machinery of two of the world's most neglected killers, a quiet revolution in drug discovery is ...
Researchers at the University of Liège and Rockefeller University have captured near-atomic-resolution cryo-EM structures of the trans-spliceosome, the essential RNA-processing ...
A ten-year surveillance program in the Argentine Chaco found that the secondary Chagas vector Triatoma sordida carries very low Trypanosoma ...
A large-scale reanalysis of 86 RNA-seq libraries shows that the developmental gene expression programs of Trypanosoma cruzi are largely conserved ...
A study of 901 Triatoma infestans bugs in Argentina shows that rare melanic individuals occur only in rural areas, form ...
The TESEO trial shows that a 30-day once-daily benznidazole regimen is as effective as the 60-day standard treatment for chronic ...
Brazilian researchers show that Rhodnius neglectus bugs living in carnaúba palms can mimic the light brown coloration of Rhodnius nasutus, ...
A synthetic azobenzenoid compound called CaCS2 shows broad-spectrum activity against Leishmania amazonensis and Trypanosoma cruzi with low human cell toxicity, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine